Observers are sceptical about major asset sales to earn regulatory approval, as shareholders of Orbital ATK today overwhelmingly accepted the company’s US$9.2bn sale to Northrop Grumman. If regulators conclude that there is duplication, they are not likely to see it in… Observers are sceptical about major asset sales to earn regulatory approval, as shareholders of […]